SOGROYA may inhibit 11βHSD-1 and reduce serum cortisol concentrations, potentially requiring increased glucocorticoid maintenance or stress doses.
Source: NLP:somapacitan-beco
3 interactions on record
SOGROYA may inhibit 11βHSD-1 and reduce serum cortisol concentrations, potentially requiring increased glucocorticoid maintenance or stress doses.
Source: NLP:somapacitan-beco
NGENLA may inhibit 11βHSD-1 and reduce serum cortisol concentrations. Patients on cortisone acetate replacement for hypoadrenalism may require increased maintenance or stress doses.
Source: NLP:somatrogon-ghla
Patients treated with cortisone acetate for hypoadrenalism may require increased maintenance or stress doses following somatropin initiation.
Source: NLP:somatropin